Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astrana HealthASTH +1.07%76 3-Year Book Growth Rate is 11.00% as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 76/100 and a GF Value™ of $83.93 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Astrana Health ranks better than 64.66% on this metric.
During the past 12 months, Astrana Health's average Book Value per Share Growth Rate was 7.50% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 11.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 14.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Astrana Health was 29.70% per year. The lowest was -104.90% per year. And the median was -16.90% per year.
Astrana Health (NAS:ASTH) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Astrana Health 3-Year Book Growth Rate Related Terms
ASTH vs SNDA, SGRY, AVAH: 3-Year Book Growth Rate Comparison
For the Medical Care Facilities subindustry, Astrana Health's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Astrana Health's 3-Year Book Growth Rate falls into.
Astrana Health 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 11.00% mean?
Astrana Health (ASTH) has a 3-Year Book Growth Rate of 11.00% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #205 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 35.3%.
Is Astrana Health's 3-Year Book Growth Rate too high?
Astrana Health's current 3-Year Book Growth Rate is 11.00%. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.50. Astrana Health's value of 11.00% is 100% above this industry median. Based on the distribution chart, Astrana Health ranks #205 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Astrana Health has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's 3-Year Book Growth Rate compare to SNDA and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #205 out of 580 companies for 3-Year Book Growth Rate. This puts Astrana Health in the upper half of its industry. The industry median 3-Year Book Growth Rate is 5.50. Astrana Health's value of 11.00% is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.50, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current 3-Year Book Growth Rate of 11.00% is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current 3-Year Book Growth Rate is 11.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.93, compared to a current price of $36.03 — trading 57.1% below its estimated fair value. The current 3-Year Book Growth Rate is 11.00% and 100% above the Healthcare Providers & Services industry median of 5.50. Astrana Health's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Astrana Health (ASTH), the current 3-Year Book Growth Rate is 11.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $36.03 is trading 57.1% below its estimated GF Value™ of $83.93.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
3-Year Book Growth Rate: 11.00%
GF Value™: $83.93 vs. price of $36.03 (57.1% below fair value)
Industry Position: 100% above the Healthcare Providers & Services median (#205 of 580)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
76GF Score
Get the complete analysis for ASTH
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
